VLC
MRK icon

Van Leeuwen & Company’s Merck MRK Stock Holding History

Van Leeuwen & Company’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$335K Buy
2,538
+444
+21% +$54.7K 0.17% 76
2023
Q4 		$228K Buy
2,094
+24
+1% +$2.49K 0.13% 81
2023
Q3 		$213K Sell
2,070
-661
-24% -$71.2K 0.13% 77
2023
Q2 		$312K Buy
2,731
+11
+0.4% +$1.25K 0.2% 59
2023
Q1 		$289K Sell
2,720
-12,247
-82% -$1.32M 0.19% 65
2022
Q4 		$1.66M Sell
14,967
-5,249
-26% -$537K 1.15% 26
2022
Q3 		$1.74M Buy
20,216
+9,028
+81% +$806K 1.39% 24
2022
Q2 		$1.02M Sell
11,188
-5,255
-32% -$466K 0.85% 30
2022
Q1 		$1.35M Buy
+16,443
New +$1.3M 0.99% 28
2020
Q2 		– Sell
-24,933
Closed -$1.83M – 80
2020
Q1 		$1.83M Buy
24,933
+1,380
+6% +$108K 1.76% 22
2019
Q4 		$2.04M Buy
23,553
+19,335
+458% +$1.59M 1.7% 24
2019
Q3 		$339K Sell
4,218
-264
-6% -$21.2K 0.32% 60
2019
Q2 		$359K Buy
4,482
+1,692
+61% +$130K 0.32% 65
2019
Q1 		$221K Sell
2,790
-47
-2% -$3.52K 0.21% 73
2018
Q4 		$207K Buy
+2,837
New +$200K 0.21% 73

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Van Leeuwen & Company's MRK Position: Q1 2024 in Review

Van Leeuwen & Company increased its Merck (MRK) stake by 21% in Q1 2024, buying an estimated $54.7K and bringing the position to 2,538 shares worth $335K. The position accounts for 0.17% of the portfolio, ranked #76.

Van Leeuwen & Company first reported a position in MRK in Q4 2018 and has held it in 15 quarters since. The position peaked at $2.04M in Q4 2019. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Van Leeuwen & Company held 2,538 shares of Merck worth $335K as of Q1 2024.
  • Van Leeuwen & Company bought 444 Merck shares in Q1 2024, an estimated $54.7K.
  • Merck made up 0.17% of Van Leeuwen & Company's portfolio in Q1 2024, its #76 holding.
  • Van Leeuwen & Company first reported a position in Merck in Q4 2018 and has held it in 15 quarters since.
  • Van Leeuwen & Company's Merck position peaked at $2.04M in Q4 2019.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Van Leeuwen & Company's 13F filing for Q1 2024, filed 10 May 2024.